Teriparatide

Type: Keyphrase
Name: Teriparatide
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

Eli Lilly 2nd-qtr sales takes hit from generics; net income falls 39%

US pharma major Eli Lilly (NYSE: LLY) reported second quarter 2014 revenues fell 17% to $4.935 billion, reflecting generic competition for Cymbalta (duloxetine) and Evista (raloxifene) in the USA.However, revenues still exceeded the Zacks Equity Research ... [Published Pharma Letter - Jul 25 2014]
First reported Jul 23 2014 - Updated Jul 24 2014 - 1 reports

Ultragenyx Appoints Sunil Agarwal, M.D. as Chief Medical Officer and Senior Vice President

(GLOBE NEWSWIRE) -- . (Nasdaq:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced it has appointed Sunil Agarwal, M.D. as its Chief Medical Officer and Senior Vice President, ... [Published EMoneyDaily - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

New Findings on Postmenopausal Osteoporosis Reported by S.S. Maeda et al (An overview on the treatment of postmenopausal osteoporosis)

By a News Reporter-Staff News Editor at Clinical Trials Week -- New research on Metabolic Bone Diseases is the subject of a report. According to news reporting out of Sao Paulo, Brazil , by NewsRx editors, research stated, "Osteoporosis is a worldwide ... [Published 4 Traders - Jul 23 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Human medicines European public assessment report (EPAR): Forsteo, teriparatide, Revision: 15, Authorised

Entities: Forsteo, Teriparatide
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

New agent builds bone bigger, faster

CHICAGO – Abaloparatide, a synthetic analog of human parathyroid hormone–related peptide, displayed jaw-dropping superiority to teriparatide in boosting bone mineral density at multiple anatomic... ... [Published Ob.Gyn. News - Jul 18 2014]
First reported Jul 13 2014 - Updated Jul 13 2014 - 1 reports

Abstract and Introduction – Medscape

Abstract and IntroductionMedscapeObjectives To quantify incremental effects of applying different criteria to identify men who are candidates for drug treatment to prevent fracture and to examine the extent to which fracture probabilities vary across ... [Published ISCD - Jul 13 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

Drug Treatment to Prevent Fracture in Older Men in US

Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res 2007;22:465-75.Johnell O, Kanis J. Epidemiology of osteoporotic fractures. ... [Published General Medicine eJournal - Jul 11 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 1 reports

Remote-controlled contraception on the horizon

Implantable device being developed by MicroCHIPS could dispense birth control or other medications. MicroCHIPSRemote-controlled contraception could be the next big advance in birth control.According to MIT Technology Review , the Bill and Melinda Gates ... [Published CBS News - Jul 08 2014]
First reported Jul 07 2014 - Updated Jul 08 2014 - 2 reports

Remote-Controlled Birth Control May Be In Your Near Future

Lexington-based startup MicroCHIPS is aiming to release remote-controlled contraceptive into preclinical testing in 2015. The proposed device delivers a daily dose of 30 micrograms of levonorgestrel — the active ingredient in some forms of oral contraception ... [Published boston.com - Jul 08 2014]
First reported Jun 16 2014 - Updated Jun 16 2014 - 2 reports

Chemical strategy hints at better drugs for osteoporosis, diabetes

MADISON, Wis. By swapping replacement parts into the backbone of a synthetic hormone, UWMadison graduate student Ross Cheloha and his mentor, Sam Gellman, along with collaborators at Harvard Medical School, have built a version of a parathyroid hormone ... [Published Bio-Medicine - Jun 16 2014]
First reported Jun 16 2014 - Updated Jun 16 2014 - 1 reports

Teriparatide Shows Promise for Fusing Spine, Researchers Report

Injections of teriparatide could encourage bony healing and fusion in the spine and prevent future fractures in patients with osteoporosis, according to research presented at the American Association of Clinical Endocrinologists 23rd Annual Scientific ... [Published ODT Mag - Jun 16 2014]
First reported Apr 09 2014 - Updated Apr 09 2014 - 1 reports

Critical Pharmaceuticals receives notice of allowance from USPTO for two hormone products

Critical Pharmaceuticals has announced that the US Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application directed towards the company's CP024 intranasal growth hormone and CP046 intranasal teriparatide (parathyroid ... [Published PBR - News - Apr 09 2014]

Quotes

...us great confidence that Lilly is poised for growth in the years ahead," said John Lechleiter, Lilly's chairman president and chiefchief executive. "We have stayed the course with our innovation-based strategy, replenishing and advancing our pipeline. We remain firm in our commitment to sustain and accelerate a flow of important new medicines that make life better for people around the world" he added
According to the news editors, the research concluded: "Based on the knowledge on bone cells signaling, novel drugs were developed and are being assessed in clinical trials."
...Agarwal. "To develop novel therapies for these patients who have no approved treatments and to help push the science forward in these rare genetic diseases is something I am thrilled to be a part of."
But the real excitement of the discovery is the potential impact on a large class of peptide drugs, Gellman says. "A substantial group of receptors, including some involved in diabetes, respond to peptide signals, but peptides are quickly degraded in the body. Our appro"

More Content

All (19) | News (16) | Reports (0) | Blogs (3) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Eli Lilly 2nd-qtr sales takes hit from generics... [Published Pharma Letter - Jul 25 2014]
New Findings on Postmenopausal Osteoporosis Rep... [Published 4 Traders - Jul 23 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Jul 23 2014]
Ultragenyx Appoints Sunil Agarwal, M.D. as Chie... [Published EMoneyDaily - Jul 23 2014]
New agent builds bone bigger, faster [Published Ob.Gyn. News - Jul 18 2014]
Abstract and Introduction – Medscape [Published ISCD - Jul 13 2014]
Drug Treatment to Prevent Fracture in Older Men... [Published General Medicine eJournal - Jul 11 2014]
Remote-controlled contraception on the horizon [Published CBS News - Jul 08 2014]
Remote-Controlled Birth Control May Be In Your ... [Published boston.com - Jul 08 2014]
MicroCHIPS develops contraceptive implant [Published PhysOrg.com - Jul 07 2014]
Chemical strategy hints at better drugs for ost... [Published Bio-Medicine - Jun 16 2014]
Chemical strategy hints at better drugs for ost... [Published EurekAlert! - Jun 16 2014]
Teriparatide Shows Promise for Fusing Spine, Re... [Published ODT Mag - Jun 16 2014]
Critical Pharmaceuticals receives notice of all... [Published PBR - News - Apr 09 2014]
On the Move [Published Argus Leader - Mar 24 2014]
Sanford announces seed grant research funding w... [Published Argus Leader - Mar 21 2014]
Can Novel-Novel Combinations Work? Deals Of The... [Published The IN VIVO Blog - Feb 07 2014]
Combination treatment with strontium for the pr... [Published PharmCast - Jan 22 2014]
5 Osteoporosis Assumptions: Myth or Fact? [Published ThirdAge - Nov 06 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Jul 23 2014]
Critical Pharmaceuticals receives notice of all... [Published PBR - News - Apr 09 2014]
Critical Pharmaceuticals has announced that the US Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application directed towards the company's CP024 intranasal growth hormone and CP046 intranasal teriparatide (parathyroid ...
Can Novel-Novel Combinations Work? Deals Of The... [Published The IN VIVO Blog - Feb 07 2014]
Merck & Co. Inc.’s Feb. 5 announcement that it is collaborating with three companies to test various combinations of its investigational oncology compound MK-3475 with their drugs highlights the extent to which the big pharma is committed to building ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.